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lood Rheology and Renal Transplantation: An Intriguing Relationship
or Assessing Cardiovascular Risk
. Zanazzi, C. Fatini, S. Farsetti, G. Rosso, L. Caroti, E. Sticchi, A.A. Liotta, I. Ricci, L. Mannini,
. Bertoni, R. Abbate, and M. Salvadori
ABSTRACT
Renal transplant recipients (RTRs) are at increased risk of cardiovascular complications.
An altered hemorheological profile may determine both cardiovascular complications and
progression of renal failure in RTRs. We performed this study to evaluate the rheologic
status in 239 RTRs at least 12 months after transplantation with stable and normal renal
function compared with 90 control subjects. In RTRs, a significantly higher hematocrit-
adjusted, but not native, whole blood viscosity was found (P  .0001). Moreover, plasma
viscosity and red blood cell deformability were significantly higher in patients than in
control subjects (P  .0001), whereas no difference in erythrocyte aggregation between
patients and control subjects was observed (P  .5). Fibrinogen, but not hematocrit,
significantly increased in RTRs (P  .001). This preliminary study provides evidence of an
























ardiovascular disease is the main cause of mortality
and morbidity in transplant recipients. Traditional
isk factors, such as smoking habit, hypertension, dyslipide-
ia, and diabetes, do not completely account for the high
ncidence of cardiovascular risk in these patients. Novel
arkers of cardiovascular risk, such as an altered hemo-
heologic profile may influence cardiovascular mortality in
hese patients. Clinical studies1 provided evidence that
bnormalities in blood flow properties may contribute to
ardiovascular events, and an altered hemorheologic pro-
le, which worses microcirculatory blood flow and influ-
nces vascular disease, might determine both cardiovascu-
ar complications and progression of renal failure in renal
ransplant recipients (RTRs). Few data are available con-
erning the impact of blood rheology in affecting cardiovas-
ular risk in RTRs.2,3 We performed the present study to
nvestigate the rheologic status in RTR patients at least 12
onths after transplantation with stable and normal renal
unction.
ETHODS
e investigated 239 RTR patients at least 12 months after
ransplantation with stable and normal renal function [156 men,
edian age 53 (range 17–75) y; 83 women, median age 50 (range
7–74) y] compared with 90 control subjects [38 men, median age
8 (range 22–63) y; 52 women, median age 41 (range 26–61) y]
ith no history of renal or cardiovascular disease. Patients and
ontrol subjects gave their informed consents and the study was 5
2010 Published by Elsevier Inc.
60 Park Avenue South, New York, NY 10010-1710
ransplantation Proceedings, 42, 1383–1384 (2010)pproved by the local Ethics Committee. Hemorheologic profile
as performed by assessing both whole-blood viscosity (at shear
ates of 0.512 and 94.5/s), plasma viscosity, erythrocyte deform-
bility and aggregability, and coagulation parameters (hemoglo-
in, hematocrit, and fibrinogen concentrations) as previously
escribed.4
tatistical Analysis
ata are reported as mean  SD and median (range) for nonpara-
etric parameters, and the comparison between patients and
ontrols was performed with the Mann-Whitney U test. All prob-
bility values were two tailed, with values of .05 considered to be
tatistically significant.
ESULTS
n RTRs, a significantly higher hematocrit-adjusted, but not
ative, whole blood viscosity was found (P  .0001).
oreover, plasma viscosity and red blood cell deformability
ere significantly different between patients and control
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1384 ZANAZZI, FATINI, FARSETTI ET ALubjects (P  .0001), whereas no difference in erythrocyte
ggregation between patients and controls subjects was
bserved (P  .5). Fibrinogen, but not hematocrit, signifi-
antly increased in RTRs (P  .001). Significantly lower
emoglobin values were observed in RTRs than in control
ubjects (P  .0001).
ISCUSSION
his study provides evidence of an altered hemorheologic
rofile in RTRs compared with healthy subjects. In partic-
lar, we observed a significant difference in hematocrit-
djusted whole blood viscosity and in both plasma viscosity
nd erythrocyte deformability, which is known to influence
lood rheology. Of interest, the finding of a higher hematocrit-
djusted whole blood viscosity is in line with clinical data
hat in patients with chronic kidney disease, an early
omplete correction of anemia did not reduce the risk of
ardiovascular events.5 RTRs are known to be at greatly
ncreased risk of cardiovascular morbidity and mortality
ompared with the general population,6 and have an in-
reased incidence of atherosclerotic plaques and other
ascular alterations compared with control subjects.7,8 Tra-
itional risk factors, such as hypertension, smoking habit,
iabetes, and dyslipidemia, are well known to increase the
isk of cardiovascular disease in RTRs and thus possibly
redict the incidence of cardiovascular events. Accordingly,
n altered rheologic profile, which is known to influence
ardiovascular risk,1 may contribute to implement the risk 1rofile panel in RTRs. In conclusion, our findings might
uggest a contribution in assessing cardiovascular risk in
TRs to prevent cardiovascular complications. Neverthe-
ess, further studies are required to confirm this preliminary
ata. A tailored pharmacologic intervention, aimed to
orrect the rheologic milieu, might permit reducing cardio-
ascular risk in these patients.
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